Antihypertensive Activity of Aqueous Celery (Apium graveolens) Leaf Extract at Different Dose Levels in a NaCl-Induced Hypertensive Murine Model
DOI:
https://doi.org/10.29303/jk.v15i3.10027Kata Kunci:
Apium graveolens, celery leaf extract, hypertension, antihypertensive activity, herbal medicineAbstrak
Background: Hypertension is a major risk factor for cardiovascular disease, and there is increasing interest in herbal medicines as complementary antihypertensive therapies. Celery (Apium graveolens) has been reported to possess antihypertensive properties; however, evidence comparing the effects of different doses of celery leaf extract remains limited.
Objective: To evaluate the antihypertensive activity of aqueous celery (Apium graveolens) leaf extract at different dose levels in a NaCl-induced hypertensive murine model.
Methods: Twenty-four male mice were rendered hypertensive by administration of 2% NaCl for seven days and were then randomly assigned to four groups (n = 6 per group): a control group and three treatment groups receiving aqueous celery leaf extract at doses of 300, 400, and 500 mg/kg body weight/day for seven consecutive days. Blood pressure was measured at baseline (Day 0), after hypertension induction (Day 7), and after treatment (Day 14). Post-treatment systolic and diastolic blood pressure values were compared among groups using one-way ANOVA followed by Tukey's honestly significant difference (HSD) test.
Results: All treatment groups exhibited lower post-treatment systolic and diastolic blood pressure values than the control group. The 300 mg/kg body weight/day group showed the lowest post-treatment blood pressure values among the tested doses; however, no statistically significant differences were observed among the three treatment groups. Significant differences were identified between each treatment group and the control group (p < 0.05).
Conclusion: Aqueous celery (Apium graveolens) leaf extract demonstrated antihypertensive activity in NaCl-induced hypertensive mice. Within the tested dose range, increasing the dose above 300 mg/kg body weight/day did not provide additional antihypertensive benefit. Further studies evaluating a wider range of doses, longer treatment durations, and maintenance of the hypertensive stimulus are warranted to better characterize the antihypertensive potential of celery leaf extract.
Unduhan
Diterbitkan
Terbitan
Bagian
Lisensi
Hak Cipta (c) 2026 Abraham Ahmad Ali Firdaus, Marselli W. Lestari, Durroh Putri, Ain Darojah Siddiq Ramadhana

Artikel ini berlisensi Creative Commons Attribution 4.0 International License.
Authors who publish with Unram Medical Journal, agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License (CC-BY License). This license allows authors to use all articles, data sets, graphics, and appendices in data mining applications, search engines, websites, blogs, and other platforms by providing an appropriate reference. The journal allows the author(s) to hold the copyright without restrictions and will retain publishing rights without restrictions.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in University of Mataram's Journal of Medicine.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
- This journal is open access journal which means that all content is freely available without charge to users or / institution. Users are allowed to read, download, copy, distribute, print, search, or link to full text articles in this journal without asking prior permission from the publisher or author.








